Home › Kanser sa Pancreas › Florida › Tampa
Pag-aaral pangklinika para sa Kanser sa Pancreas sa Tampa, FL
26 pag-aaral para sa Kanser sa Pancreas ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Tampa (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
Nagre-recruitPhase 3
- Moffitt Cancer Center, Tampa
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Nagre-recruitPhase 1
- Moffitt Cancer Center, Tampa
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Nagre-recruitObservasyonal na pag-aaral
- Moffitt Cancer Center, Tampa
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Nagre-recruitPhase 1/2
- Moffitt Cancer Center, Tampa
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Nagre-recruitPhase 1/2
- Moffitt Cancer Center and Research Institute, Tampa
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Nagre-recruitPhase 1/2
- Moffitt Cancer Center, Tampa
Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer
Nagre-recruit
- Moffitt Cancer Center, Tampa
Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma
Nagre-recruitPhase 3
- Moffitt Cancer Center, Tampa
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Nagre-recruitPhase 2
- Moffitt Cancer Center, Tampa
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Nagre-recruitPhase 3
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens
Nagre-recruit
- Moffitt Cancer Center, Tampa
Pancreatic Cancer Early Detection Consortium
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Moffitt Cancer Center, Tampa
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Nagre-recruitPhase 1
- Moffitt Cancer Center, Tampa
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Nagre-recruitPhase 1/2
- Moffitt Cancer Center, Tampa
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
Nagre-recruitPhase 1
- Moffitt Cancer Center, Tampa
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
Nagre-recruitPhase 1
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Tampa
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Nagre-recruitPhase 1
- Lee Moffitt Cancer Center, Tampa
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Nagre-recruitPhase 1/2
- Moffitt Cancer Center, Tampa
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Nagre-recruitPhase 3
- Moffitt Cancer Center - McKinley Campus, Tampa
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Nagre-recruitPhase 2
- Ohio State University-Telemedicine, Tampa
A First-in-Human Study of FID-022 in Solid Tumor Patients
Nagre-recruitObservasyonal na pag-aaral
- Moffitt Cancer Center, Tampa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Tampa
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- Exelixis Clinical Site #16, Tampa
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Nagre-recruitPhase 1
- H. Lee Moffitt Cancer Center and Research Institute, Inc, Tampa
Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source
Nagre-recruitPhase 1/2
- Tampa General Hospital, Tampa
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
Nagre-recruitObservasyonal na pag-aaral
- University of South Florida, Tampa
Pag-aaral para sa Kanser sa Pancreas sa ibang lungsod
- Houston, TX61 pag-aaral
- New York City, NY60 pag-aaral
- Boston, MA43 pag-aaral
- Nashville, TN39 pag-aaral
- Los Angeles, CA35 pag-aaral
- St. Louis, MO33 pag-aaral
- Arlington, VA33 pag-aaral
- Baltimore, MD31 pag-aaral
- San Antonio, TX31 pag-aaral
- Philadelphia, PA26 pag-aaral
- Durham, NC24 pag-aaral
- San Diego, CA24 pag-aaral
Iba pang pag-aaral sa Tampa
- Non-Small Cell Lung Cancer51 pag-aaral
- Kanser sa Suso43 pag-aaral
- Kanser (lahat ng uri)39 pag-aaral
- Colorectal Cancer34 pag-aaral
- Acute Myeloid Leukemia29 pag-aaral
- Metastatic Cancer29 pag-aaral
- Kanser sa Baga29 pag-aaral
- Kanser sa Ovary21 pag-aaral
- Melanoma19 pag-aaral
- Myelodysplastic Syndromes19 pag-aaral
- Kanser sa Prostate18 pag-aaral
- Pagkabigo ng Puso18 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.